Back to All

Diaceutics wins Made in Northern Ireland 2019 Award

13 May, 2019

Diaceutics is delighted to announce that it has been honoured with a Made in Northern Ireland 2019 award. Held on Friday 10th May at the Titanic Hotel, Belfast, the annual awards celebrate the innovative businesses contributing to Northern Ireland’s success.

Diaceutics was named winner in the Medical, Life Sciences and Healthcare category. Other nominees in the category were Fortress Diagnostics, Nicobrand and Trucorp.

Damian Thornton, Chief Operating Officer, Diaceutics, accepted the award on behalf of the Diaceutics team. He said: “This award means a great deal to all of us in Diaceutics. We are a global company with operations across four continents, but Northern Ireland is in our DNA. Diaceutics was founded in Belfast on a mission to give more patients access to precision medicine therapies by improving the diagnostic testing landscape. Now we are a London Stock Exchange listed company and we recently opened our Asian headquarters in Singapore. The support of the Northern Irish business community has been essential to our success.”

In March, Diaceutics became the fourth Northern Irish company currently listed on the London Stock Exchange when it announced its IPO on the AIM market.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.